#United States #oncology #Virginia Cancer Specialists #NCODA #Fairfax, Virginia

Virginia Cancer Specialists Achieves NCODA Accreditation

Fairfax, Virginia – December 4, 2024 – Virginia Cancer Specialists (VCS), the largest private cancer clinic in Northern Virginia, proudly announces its recent designation as a fully accredited facility by the NCODA's Center of Excellence Medically Integrated Pharmacy Program. This recognition signifies VCS’s dedication to delivering the highest standards in cancer care, reinforcing its commitment to patient-centered treatment protocols.

A Commitment to Quality Care

Accredited by the National Community Oncology Dispensing Association (NCODA), VCS stands at the forefront of oncology practices. The NCODA is a prominent non-profit organization that focuses on enhancing patient care through medically integrated practices. This accreditation serves as a stamp of approval, confirming that VCS meets the stringent standards necessary to provide exceptional cancer care, which includes an array of integrated pharmacy services.

According to a statement from Marie Garcia, RN, OCN, Director of Clinical Operations at Virginia Cancer Specialists, "The advancements made in oral cancer therapies have dramatically changed the way cancer treatment is delivered for many patients. With a medically integrated pharmacy within our practice, patients can conveniently pick up their prescriptions directly from our clinic. This process not only enhances the quality of services but also leads to improved patient outcomes and significant cost savings."

Improved Patient Outcomes

The accredited pharmacy program is designed to streamline patient access to oncolytic medications. By reducing wait times and potential errors in medication dispensing, VCS can ensure faster treatment initiation and adherence, which are crucial components in successful cancer management. Moreover, the program minimizes waste by avoiding unnecessary costs, thus benefiting all stakeholders involved, including providers, employers, payers, and pharmaceutical companies.

Benefits of Medically Integrated Pharmacy

1. Faster Access to Medications: Patients benefit from expedited processes that allow them to receive their prescribed medications without the delays typically associated with traditional pharmacies.
2. Enhanced Clinical Coordination: By incorporating pharmacy services into their practice, VCS ensures that patient care remains cohesive and collaborative, reducing fragmentation in treatment plans.
3. Increased Satisfaction: Both patients and clinicians report higher satisfaction levels due to the seamless nature of care delivery fostered by the integrated pharmacy model.

Milestones and Achievements

Virginia Cancer Specialists has established itself as an industry leader, with recognition as the #1 physician practice in Virginia for cancer care by Castle Connolly. With a comprehensive treatment regimen that includes medical oncology, radiation oncology, and access to clinical trials through the Virginia Cancer Specialists Research Institute, VCS remains dedicated to advancing cancer treatment.

Bob Patman, Senior Vice President of Operations for The US Oncology Network, expressed his pride in VCS’s achievements, stating, "This accreditation is a massive milestone for the practice. It’s a testament to the relentless commitment each team member demonstrates in delivering superior care to our patients."

About Virginia Cancer Specialists

Virginia Cancer Specialists is a key player in The US Oncology Network, which consists of over 2,600 independent healthcare providers geared towards providing patient-focused and integrated cancer care. This collaboration allows VCS to utilize shared expertise and resources to enhance the quality of care offered to patients, ensuring they receive superior treatment right in their communities. The partnership with McKesson Corporation further strengthens VCS’s commitment to patient health by focusing on operational efficiencies.

For over three decades, VCS has set itself apart through its participation in clinical trials, contributing to groundbreaking research in cancer therapies. Their collaboration with the Sarah Cannon Research Institute embodies their dedication to advancing medical innovations in oncology, ensuring that patients receive cutting-edge therapies.

About NCODA

The National Community Oncology Dispensing Association (NCODA) is recognized for its efforts in enhancing patient care standards in oncology. By focusing on quality improvement and best practices, it supports oncology practices to foster better health outcomes for patients navigating the challenges of cancer treatment. Since its inception in 2015, NCODA has positively influenced over 3,000 practices worldwide, aligning various stakeholders in the fight against cancer.

For more information about Virginia Cancer Specialists and the services they provide, please visit their website or contact their offices directly.